Swiss Healthtech Stock News

Alcon stock closed at CHF61.06 on 11 August after a strong run over the past quarter. Yet the real story now sits in the income statement. Q2 sales landed at about US$2.8b with 7% growth, but the headline tension for investors is profits. Trailing 12 month net profit margin is 5.9% compared with 10.7% a year earlier, held back by a US$453m one off loss that still hangs over reported earnings. For anyone thinking beyond this quarter, the key question is how quickly those margins can rebuild as...

Bell Food Group stock closed at CHF191.60 ahead of the half year 2026 release, with the market already leaning cautiously higher in recent weeks. The earnings headline is not the top line. The key story is a profit profile that remains tight, with trailing net margin sitting at 1.6% and earnings over the past five years declining at an annualised rate of 7.4%. That mix keeps the focus squarely on whether this low margin food producer can turn a modest P/E of 15.2x into something stronger over...

Tecan Group stock closed at CHF181.2 on the day of its half year 2026 report, after a choppy few months that left the shares down over the past week but still well ahead over ninety days. The headline is not the top line. The real story is a margin picture under pressure, with gross margin slipping while adjusted EBITDA margin held at 15.1% and cash generation came in soft at CHF17m. Short term traders are reacting to squeezed profitability. Long term holders now have to judge whether the...

Adecco Group (SWX:ADEN) is in focus after reporting half year 2026 results that showed slightly higher sales but a small decline in net income, raising fresh questions about earnings quality and stock valuation. See our latest analysis for Adecco Group. Adecco Group's latest earnings update arrives after a strong run in the share price. The 30 day share price return is 35.98% and the 90 day share price return is 54.89%. However, the 1 year total shareholder return is still down 5.37%, which...

ARYZTA stock came into today on the back foot, with the share price down about 18% over the past three months. However, the latest earnings headline is less about the income statement and more about the balance sheet. The company still carries a high level of debt, which now sits against a business generating trailing net income of just over €100m and a net margin under 5%. For you as an investor, the key question after this set of numbers is simple: does the current P/E discount and heavy...

In late July 2026, Logitech International reported first-quarter sales of US$1,227.23 million and net income of US$235.7 million, while issuing second-quarter fiscal 2027 sales guidance of US$1,185 million to US$1,220 million and completing a US$100.78 million buyback of 926,000 shares. Logitech’s Streamlabs unit also introduced Network Boost for Streamlabs Ultra, turning everyday smartphones into bonded Wi‑Fi and cellular links to improve mobile stream reliability and expand higher-margin...

INFICON Holding earnings jump and guidance raised INFICON Holding (SWX:IFCN) reported half-year 2026 sales of US$379.14 million and net income of US$55.41 million, with basic earnings per share from continuing operations at US$2.27. The company also raised its full-year 2026 outlook and is now guiding for sales between US$750 million and US$780 million and an operating income margin of 19% to 20% as of July 30, 2026. See our latest analysis for INFICON Holding. INFICON Holding’s share price...

European markets have recently shown resilience, with the pan-European STOXX Europe 600 Index rising by 1.70%, supported by firm risk appetite and stable earnings despite ongoing geopolitical volatility. As investors navigate these conditions, identifying stocks that are potentially undervalued compared to their intrinsic worth can offer opportunities for those looking to capitalize on market inefficiencies.

Clariant (SWX:CLN) has drawn fresh attention after reporting half year 2026 earnings that combined lower sales with higher profitability, including stronger net income and earnings per share from continuing operations. See our latest analysis for Clariant. The latest half year earnings and the favorable court ruling at the end of July appear to have supported sentiment around Clariant, with the CHF10.10 share price reflecting a 35.39% 1 month share price return and a 41.95% year to date share...

Why OC Oerlikon Stock Is Back on Investors’ Radar OC Oerlikon (SWX:OERL) is drawing fresh attention after reporting half year 2026 results that show a move from a net loss to net income of CHF 325 million, with earnings per share turning positive. See our latest analysis for OC Oerlikon. OC Oerlikon’s latest half year earnings release on 6 August 2026, which showed a shift to net income, has coincided with a 12.11% 30 day share price return and a 48.37% year to date share price return. The 1...

Sandoz Group (SWX:SDZ) is in focus after its half year 2026 results showed sales of US$5,761 million compared with US$5,232 million a year earlier, while net income and earnings per share were materially lower. See our latest analysis for Sandoz Group. The mixed half year earnings update appears to be a key backdrop for Sandoz Group’s recent price strength, with the share price at CHF72.78 and a 1 day share price return of 5.20%. That sits within a strong run, with momentum building as the 7...

Kardex Holding (SWX:KARN) drew investor attention after issuing 2026 guidance that targets revenue growth of 15% to 20% and an EBIT margin between 8% and 10%, sharpening expectations around profitability. See our latest analysis for Kardex Holding. Over the past year, Kardex Holding has seen the share price fall year to date and over 90 days, while the 1 year total shareholder return declined 23.43%. However, the 3 year total shareholder return of 31.52% points to a stronger longer term...

Novartis (SWX:NOVN) is back in focus after the US FDA approved Pluvicto in combination with an androgen receptor pathway inhibitor for PSMA-positive metastatic hormone-sensitive prostate cancer, materially widening the therapy’s eligible patient pool. See our latest analysis for Novartis. Against this backdrop, Novartis shares trade at CHF125.98, with a 90 day share price return of 10.8% and a year to date share price return of 16.11%. The 1 year total shareholder return of 38.01% points to...

Half year earnings highlight mixed trends for Interroll Holding stock Interroll Holding (SWX:INRN) reported half year 2026 earnings with sales of CHF 269.93 million compared with CHF 247.65 million a year earlier, while net income moved to CHF 19.75 million from CHF 21.22 million. See our latest analysis for Interroll Holding. Interroll Holding's recent earnings update comes after a period where the share price has risen about 10.17% over the past month but is still down 36.59% year to date,...

Shareholders might have noticed that Amrize AG ( VTX:AMRZ ) filed its second-quarter result this time last week. The...

Guidance and half-year results put Comet Holding stock in focus Comet Holding (SWX:COTN) has drawn investor attention after issuing new earnings guidance for 2026 and reporting half year results that show higher sales, net income and earnings per share compared with a year earlier. See our latest analysis for Comet Holding. The updated 2026 guidance and stronger half year figures have come after a sharp re rating in Comet Holding, with the share price up 50.45% year to date and a 1 year total...

Investors in Swiss Re AG ( VTX:SREN ) had a good week, as its shares rose 2.7% to close at CHF139 following the release...

The market came into Mobimo Holding’s H1 2026 release already on the back foot, with the stock down over the past week, month and quarter, and sitting at CHF342.50 at yesterday’s close. Yet the headline numbers tell a more nuanced story. Reported net profit margins over the last year sit near 60%, flattered by a one off gain of CHF132.6m, while debt coverage by operating cash flow looks weak. Today's price reaction reflects that tension. Are investors correctly pricing a stretched balance...

Why Swisscom’s latest earnings are drawing investor attention Swisscom (SWX:SCMN) reported half year 2026 earnings on 6 August, with sales of CHF 7,221 million compared to CHF 7,446 million a year earlier. Net income and earnings per share both moved higher. See our latest analysis for Swisscom. Swisscom’s recent half year earnings, which showed higher net income and earnings per share alongside lower sales, come after a mixed share price pattern where the share price is up 8.64% year to date...

Idorsia Ltd recently reported half-year 2026 results showing revenue of CHF 110.25 million, a shift from net income to a net loss, while reaffirming full-year sales guidance of CHF 200 million. At the same time, Idorsia entered an exclusive agreement with Jamjoom Pharmaceuticals to distribute and commercialize its insomnia treatment QUVIVIQ across Saudi Arabia and the Levant, adding a new regional partner and revenue stream structure built on upfront, milestone, and royalty payments. Next,...

Medacta Group revenue update and why it matters for investors Medacta Group (SWX:MOVE) reported unaudited first half 2026 revenue of €368 million, compared with €344 million a year earlier. This fresh trading statement is drawing attention to how the stock’s recent performance lines up with its underlying business trends. See our latest analysis for Medacta Group. Despite the latest revenue update, Medacta Group’s share price has weakened over 2026, with a year to date share price return of...

In August 2026, ams-OSRAM reported second-quarter results showing sales of €805 million alongside a net loss of €122 million, and issued guidance for third-quarter revenues between €770 million and €870 million while signalling slightly lower full-year 2026 revenue due to divestments and foreign exchange effects. An important implication is that modest year-on-year revenue softening is driven not only by operating conditions but also by portfolio reshaping and currency headwinds, which...

Why ABB Stock Is In Focus After The LevelTen Energy Deal ABB (SWX:ABBN) has put its energy and carbon advisory business in the spotlight after announcing a partnership and minority investment in LevelTen Energy, the clean energy marketplace and software platform. See our latest analysis for ABB. ABB shares trade at CHF81.76 after easing 0.68% on the day, while the share price return since the start of the year is up 33.51% and the 5 year total shareholder return of 176.72% points to strong...

GAM Holding’s stock has been grinding higher in recent weeks, with the share price at CHF0.0828 after a strong 7 day and 30 day run. The quick win on the screen is only half the story. The fresh H1 2026 numbers highlight why this is still a high risk turnaround. The headline is the continuing earnings strain. GAM reported a loss of CHF58.2 million over the trailing twelve months on revenue of CHF48.8 million. The market sees a low P/S multiple and recent price momentum, but the key question...